CCR7 and neoplasm: It was also shown that the majority of infiltrating CTLs in tumor beds exhibited effector (CD8+CD28+), memory (CD45RO+), or activated phenotype (CD25+, CD69+, HLA-DR+) and the naive subset (expressing CD45RA and CCR7) compromised the least proportion [148,151,152].